Plus Therapeutics Reports ReSPECT-LM Phase 1 Trial Data at
Dose escalation trial demonstrates preliminary safety and efficacy results including median overall survival of 10 months for patients with leptomeningeal...
Source: globenewswire.com
Preliminary Clinical Data News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Preliminary Clinical Data. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Preliminary Clinical Data Today - Breaking & Trending Today
Fusion Pharmaceuticals to Present Interim Data from Phase 1 Trial of FPI-1434 in Patients with Solid Tumors Expressing IGF-1R
Preliminary Clinical Data with Cold/Hot Dosing Regimen Demonstrate Potential to Improve Therapeutic Index and Safety Profile Company Prioritizing Cold/Hot Dosing Regimen in Phase 1 Trial; Cohort 2 in this Arm is Currently Enrolling Data to be Presented ...
Source: marketscreener.com